Key Insights

Highlights

Treatment Research

6 treatments under study, led by Sprp

Research Leaders

5 sponsors active, led by Ruijin Hospital

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Unknown3
Withdrawn1

Clinical Trials (4)

Showing 4 of 4 trials
NCT02309502Not ApplicableWithdrawnPrimary

Panretinal Photo-stimulation in Proliferative Diabetic Retinopathy

NCT03863535Not ApplicableUnknownPrimary

PRP vs PRP+IVC for Severe nPDR

NCT01759121Not ApplicableUnknownPrimary

Safety and Effectiveness Study of 532nm Laser Subthreshold Panretinal Photocoagulation for Severe NPDR

NCT01790945Unknown

Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography

Showing all 4 trials

Research Network

Common Treatments

  • Sprp1
  • Panretinal Coagulation1
  • Tprp1
  • Green Pascal1
  • Yellow Pascal1

Active Sponsors

  • Ruijin Hospital1
  • Retina Institute of Hawaii1
  • Manchester University NHS Foundation Trust1
  • Shanghai Municipal Science and Technology Commission1
  • Sun Yat-sen University1

Top Investigators

Related Conditions

  • Moderate Nonproliferative Diabetic Retinopathy1
  • Diabete Mellitus1
  • Diabetic Macular Edema1
  • Mild Nonproliferative Diabetic Retinopathy1
  • Proliferative Diabetic Retinopathy1

Activity Timeline